COMMUNIQUÉS West-GlobeNewswire

HEXO Corp et Newstrike Brands Ltd. annoncent la clôture de l’arrangement
24/05/2019
GATINEAU, Québec et OAKVILLE, Ontario , 24 mai 2019 (GLOBE NEWSWIRE) -- Hexo Corp (« HEXO ») (TSX: HEXO; NYSE-A: HEXO) et Newstrike Brands Ltd. (« Newstrike ») (TSX-V: HIP) ont le plaisir d’annoncer la conclusion de l’ [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at Bernstein Strategic Decisions Conference
24/05/2019
DUBLIN - May 24, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 35th Annual Strategic Decisions Conference on Wednesday, May 29, 2019 [...]
JDRF welcomes Disability Advisory Committee’s recommendation that all Canadians needing life-sustaining therapy should automatically meet the criteria for the Disability Tax Credit and urges the Government to adopt this approach
24/05/2019
TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes the release of the Disability Advisory Committee’s (DAC) First Annual Report , in particular, [...]
SPINEWAY : Convocation Assemblée Générale Mixte des Actionnaires Spineway du 28 juin 2019
24/05/2019
Convocation Assemblée Générale Mixte des Actionnaires Spineway le 28 juin 2019 Modalités de mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont convoqués en Assemblée Générale [...]
VitalHub Reports Positive Earnings in Q1 2019
24/05/2019
TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families
24/05/2019
One-time treatment with Zolgensma (onasemnogene abeparvovec-xioi) is designed to replace lifetime of chronic therapy for all pediatric patients with SMA Annualized cost of Zolgensma is USD 425,000 per year for 5 years: [...]
AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)
24/05/2019
SMA is a rare genetic disease that leads to progressive muscle weakness, paralysis and, when left untreated in its most severe form, permanent ventilation or death for most patients by age 2[1],[2] Zolgensma ( [...]
IBA - Transparency notification
24/05/2019
Louvain-la-Neuve, Belgium, May 24, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA – Publication relative à une notification de transparence
24/05/2019
Louvain-la-Neuve, Belgique, 24 mai 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Inventiva to Present at the Jefferies 2019 Healthcare Conference
24/05/2019
Inventiva to Present at the Jefferies 2019 Healthcare Conference Daix (France), May 24, 2019 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the [...]
Inventiva participera à la « Jefferies 2019 Healthcare Conference »
24/05/2019
Inventiva participera à la « Jefferies 2019 Healthcare Conference » Daix (France), le 24 mai 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules [...]
XBiotech annonce un projet de lancement d'une étude randomisée de phase 2b du bermekimab pour le traitement de l'hidradénite suppurée
24/05/2019
AUSTIN, Texas, 24 mai 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) annonce des projets d'avancement de son programme de dermatologie concernant son anticorps humain bermekimab, avec le lancement d'une étude [...]
Respected Natural Products Marketing Strategist Mike Danielson Accepts Position on Trident Brands Inc. Advisory Board
24/05/2019
Brookfield, WI, May 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT) today announced that respected natural products marketing strategist Mike Danielson has accepted a position on [...]
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
24/05/2019
CHARLOTTESVILLE, Va., May 24, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced that it has entered into a definitive securities [...]
Aura Initiates Investor Relations Strategy
24/05/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, May 24, 2019 (GLOBE [...]
Eve & Co Announces Financial Results for the Three Month Period Ended March 31, 2019
24/05/2019
TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce its interim financial results for the three month period ended March [...]
Canada House Wellness Group Announces First Harvest from its Licensed Facility
24/05/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Wildflower Featured in CannabisNewsAudio Broadcast Discussing Rising Media Attention in Support of CBD
24/05/2019
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, “Celebrity Attention Fuels Rising [...]
Tyme Technologies To Host a Conference Call for the Fourth Quarter and Fiscal Year 2019 Financial and Operating Results on May 29, 2019
24/05/2019
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that the company will host a [...]

Pages